Relationship between hypotensive effects and plasma concentrations of clonidine in spontaneously hypertensive rats: continuous treatment and sudden termination of clonidine infusion. 1994

T Naruse, and T Ishida, and R Ishii, and T Tagawa, and K Namba
Central Research Laboratories, Maruho Co., Ltd, Osaka, Japan.

1. Clonidine was administered subcutaneously (62.5, 125 and 250 micrograms/kg/day) for 8 days using an osmotic infusion pump in spontaneously hypertensive rats (SHR). Clonidine, administered at 125 and 250 micrograms/kg/day at 48 hr after infusion, respectively, and thereafter were maintained at this level throughout the infusion period. 3. After terminating clonidine infusion, a rapid drug elimination from the plasma was manifested in both groups (125 and 250 micrograms/kg/day) with plasma clonidine levels, resulting in a decrease below 0.5 ng/ml at 4 and 6 hr, respectively. Four hours after terminating clonidine infusion at 125 and 250 micrograms/kg/day, transient but not remarkable increases in blood pressure and heart rate were observed only in the latter group compared with the values before termination. 4. These findings reveal that marked hypotensive effects were induced by relatively high doses (125 and 250 micrograms/kg/day) of clonidine in SHR, but no remarkable withdrawal symptoms after termination of clonidine infusion were observed. Therefore, unwanted withdrawal symptoms probably occur when an extremely high dose (250 micrograms/kg/day or more) of clonidine was infused for a long period (8 days or more) in SHR.

UI MeSH Term Description Entries
D007022 Hypotension Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients. Blood Pressure, Low,Hypotension, Vascular,Low Blood Pressure,Vascular Hypotension
D007260 Infusion Pumps Fluid propulsion systems driven mechanically, electrically, or osmotically that are used to inject (or infuse) over time agents into a patient or experimental animal; used routinely in hospitals to maintain a patent intravenous line, to administer antineoplastic agents and other drugs in thromboembolism, heart disease, diabetes mellitus (INSULIN INFUSION SYSTEMS is also available), and other disorders. Drug Infusion Systems,Infusion Pump,Infusion Pumps, External,Infusors,Intravenous Drug Delivery System,Intravenous Drug Delivery Systems,Perfusion Pumps,Pumps, Infusion,Drug Infusion System,External Infusion Pump,External Infusion Pumps,Infusion Pump, External,Infusion System, Drug,Infusion Systems, Drug,Infusor,Perfusion Pump,Pump, External Infusion,Pump, Infusion,Pump, Perfusion,Pumps, External Infusion,Pumps, Perfusion,System, Drug Infusion,Systems, Drug Infusion
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors

Related Publications

T Naruse, and T Ishida, and R Ishii, and T Tagawa, and K Namba
April 1995, Japanese journal of pharmacology,
T Naruse, and T Ishida, and R Ishii, and T Tagawa, and K Namba
December 1994, Hypertension (Dallas, Tex. : 1979),
T Naruse, and T Ishida, and R Ishii, and T Tagawa, and K Namba
July 1985, Japanese journal of pharmacology,
T Naruse, and T Ishida, and R Ishii, and T Tagawa, and K Namba
May 1981, Life sciences,
T Naruse, and T Ishida, and R Ishii, and T Tagawa, and K Namba
June 1980, The Journal of pharmacology and experimental therapeutics,
T Naruse, and T Ishida, and R Ishii, and T Tagawa, and K Namba
January 1994, Masui. The Japanese journal of anesthesiology,
T Naruse, and T Ishida, and R Ishii, and T Tagawa, and K Namba
November 1989, Hypertension (Dallas, Tex. : 1979),
T Naruse, and T Ishida, and R Ishii, and T Tagawa, and K Namba
December 1982, Life sciences,
T Naruse, and T Ishida, and R Ishii, and T Tagawa, and K Namba
December 1980, Clinical science (London, England : 1979),
Copied contents to your clipboard!